• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology . Epidemic influenza virus strains with high growth capability induce severe inflammatory response in vivo

tetano

Editor, Senior Moderator
Virology


. 2025 Oct 15:613:110717.
doi: 10.1016/j.virol.2025.110717. Online ahead of print. Epidemic influenza virus strains with high growth capability induce severe inflammatory response in vivo

Akeno Tsuneki-Tokunaga[SUP] 1 [/SUP], Mizuki Komatsu[SUP] 1 [/SUP], Waldy Yudha Perdana[SUP] 1 [/SUP], Shota Nishiyama[SUP] 1 [/SUP], Alfredo A Hinay Jr[SUP] 1 [/SUP], Seiji Kageyama[SUP] 1 [/SUP], Kyosuke Kanai[SUP] 2 [/SUP]



Affiliations
Abstract

Influenza epidemics occur worldwide and impose a substantial socioeconomic burden. In our previous studies, epidemic influenza virus strains isolated from seasonal influenza patient specimens exhibited a wide range of growth capabilities and demonstrated growth-dependent cell death in vitro. Based on these findings, we hypothesized that diversity in growth capabilities contributes to the severity of influenza infection. In this study, we investigated the relationship between the growth capabilities of epidemic influenza virus strains and the severity of inflammation in the bronchoalveolar cavity of inoculated mice. Our results demonstrated that high growth capability influenza A virus (IAV) strains replicated significantly faster in mice compared to low growth capability strains. High growth capability strains also induced earlier and stronger production of pro-inflammatory cytokines and promoted more rapid infiltration of inflammatory cells into the lungs. Moreover, mice infected with high growth capability strains exhibited greater weight loss and a higher mortality than those infected with low growth capability strains. These findings suggest that high growth capability IAV strains circulating in the community may induce rapid and pronounced inflammatory responses in infected individuals, leading to severe illness. Our findings may facilitate the identification of high-risk strains and support the development of improved therapeutic strategies for severe influenza cases, thereby providing new insights into the mechanisms underlying influenza severity.

Keywords: Acute respiratory distress syndrome (ARDS); Experimental infection mice model; Growth capability; Influenza virus.

 
Back
Top